Nasal spray (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Nasal spray" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2^nd place

2^nd place

3,912^th place

2,496^th place

1sciencedaily.com

993^rd place

920^th place

7,063^rd place

low place

1semanticscholar.org

11^th place

8^th place

3,984^th place

2,622^nd place

1businesswire.com

615^th place

407^th place

low place

low place

1web.archive.org

1^st place

1^st place

businesswire.com

"Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan". Pfizer. 16 November 2020. Retrieved 17 June 2024 – via Business Wire.

clincalc.com

"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
"Azelastine; Fluticasone Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.

doi.org

Rizzo MC, Solé D, Naspitz CK (2007). "Corticosteroids (inhaled and/or intranasal) in the treatment of respiratory allergy in children: safety vs. efficacy". Allergologia et Immunopathologia. 35 (5): 197–208. doi:10.1157/13110315. PMID 17923074. S2CID 13622570.
Vaidyanathan S, Williamson P, Clearie K, Kahn F, Lipworth B (July 2010). "Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion". American Journal of Respiratory and Critical Care Medicine. 182 (1): 19–24. doi:10.1164/rccm.200911-1701OC. PMID 20203244.

elsevier.es

Rizzo MC, Solé D, Naspitz CK (2007). "Corticosteroids (inhaled and/or intranasal) in the treatment of respiratory allergy in children: safety vs. efficacy". Allergologia et Immunopathologia. 35 (5): 197–208. doi:10.1157/13110315. PMID 17923074. S2CID 13622570.

nih.gov

pubmed.ncbi.nlm.nih.gov

Rizzo MC, Solé D, Naspitz CK (2007). "Corticosteroids (inhaled and/or intranasal) in the treatment of respiratory allergy in children: safety vs. efficacy". Allergologia et Immunopathologia. 35 (5): 197–208. doi:10.1157/13110315. PMID 17923074. S2CID 13622570.
Vaidyanathan S, Williamson P, Clearie K, Kahn F, Lipworth B (July 2010). "Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion". American Journal of Respiratory and Critical Care Medicine. 182 (1): 19–24. doi:10.1164/rccm.200911-1701OC. PMID 20203244.

dailymed.nlm.nih.gov

"Dymista- azelastine hydrochloride and fluticasone propionate spray, metered". DailyMed. 4 December 2024. Retrieved 20 January 2025.

sciencedaily.com

"Breakthrough: Nasal Spray May Soon Replace Pills for Delivering Drugs to the Brain". Science Daily. Science Daily. 21 May 2014. Retrieved 30 March 2015.

semanticscholar.org

api.semanticscholar.org

Rizzo MC, Solé D, Naspitz CK (2007). "Corticosteroids (inhaled and/or intranasal) in the treatment of respiratory allergy in children: safety vs. efficacy". Allergologia et Immunopathologia. 35 (5): 197–208. doi:10.1157/13110315. PMID 17923074. S2CID 13622570.

tga.gov.au

"Dymista/Dylastine (Viatris Pty Ltd)". Therapeutic Goods Administration (TGA). 1 July 2024. Retrieved 8 July 2024.

viatris.com

"Brands". Viatris. 16 November 2020. Retrieved 17 June 2024.

web.archive.org

"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.